Internship Supervisor

• Access to the top graduate students in the country
• Gain an employee with fresh insights and ideas
• Foster relationships with graduate programs and students to aid in recruiting future employees
• Achieve your organization’s goals faster with students who are highly critical and innovative thinkers

1. The internship site will identify one of its employees as the internship site supervisor to oversee the intern's work activities during his/her internship.
2. The internship site requires the student to begin his/her internship only after final McGill (Graduate and Postdoctoral Studies) approval.
3. The internship site supervisor is required to notify the student and McGill (GPS) immediately should he/she change the nature of internship which was initially approved.
4. At the end of the internship, the site supervisor will commit to completing a brief assessment of the intern: DIP Supervisor Assessment English version la version française de l'évaluation du stagiaire par le superviseur.

For FAQs, please Please refer to the FAQs here.

Would you like to participate in this program but do not have a student in mind? Would you like to be included in our database? Please enter your information here.

"My name is Hamidreza Yazdani, Research Officer at National Research Council Canada (NRC), Aerospace Portfolio. NRC is the primary national research and technology organization of the Government of Canada, in science and technology research and development. The NRC's Aerospace Research Centre is a pillar of Canada's aerospace industry, with a track record of successful collaborations with Canadian and international organizations leading to a vast opportunity in interdisciplinary and collaborative research.

Starting in 2014, NRC has invested on the development of a research program on design, simulation and advanced fabrication of bioinspired ceramic materials. We have supervised 5 PhD graduate students through this program working on different aspects of bioinspired ceramics and additive manufacturing of advanced industrial ceramics. Through this supervision, we had the chance to work with the smart and hardworking students who they spent a lot of time to make a progress in NRC projects by bringing new ideas. The team has successfully developed methods to enhance the toughness of ceramics with improve the multi-functional properties for different aerospace applications."

"The Consortium for Advancement of MRI Education and Research in Africa (CAMERA) is the leading advocate for diagnostic imaging access in Africa. CAMERA works with a global multidisciplinary network of diagnostic imaging experts to implement disruptive approaches that are advancing imaging access in Africa through training, networking, and research capacity building. Since 2018, CAMERA has focused on increasing magnetic resonance imaging (MRI) availability in Africa, to address the significant health disparity caused from poor access.

This year, CAMERA partnered with McGill University Graduate and Postgraduate Studies to provide a unique experiential learning and leadership opportunity to 6 McGill graduate students. The students collaborated with African researchers and clinicians to develop and implement two MRI training programs in 15 African countries. Thanks to the Doctoral Internship Program, the McGill students travelled across Africa and provided on-site training on how to acquire high quality MRI, analyze images, and develop state-of-the-art artificial intelligence (AI) methods for detection of diseases such as brain tumors. They made lifelong friends and laid a solid foundation to build local expertise that will support future collaborative research.

We are looking forward to continued partnership with the Doctoral Internship Program for the next team of McGill graduate students to visit Africa and work with us to make MRI and diagnostic imaging available for everyone."

"35Pharma is a clinical-stage biotech company located in Montreal that focuses on the development of innovative therapeutics in areas with urgent medical needs. Using rational design and a unique protein engineering platform, we engineer novel biologics that encompass favourable drug development properties. 35Pharma’s main area of focus targets the TGF-β superfamily of cytokines, which are known to be drivers of several life-threatening diseases, including heart failure, pulmonary hypertension, obesity, diabetes, and fibrosis.

At 35Pharma, our experienced management team has a highly successful track record in drug development, bringing internally discovered therapeutics from early preclinical development through mid-stage clinical trials in patient populations. As part of our corporate culture, we have adopted an approach designed to facilitate the transmission of this vast knowledge to young scientists, providing them with an opportunity to conduct research in an industrial setting. In recent years, we have hosted many PhD graduate students who were integrated into projects ranging from early candidate discovery, bioanalytical method development, preclinical pharmacology, translational biomarker analyses, and bioinformatics. Our work with these talented interns gave us the chance to supervise bright, committed, and hardworking young investigators who brought their own expertise to the company’s ongoing projects. Occasionally, the outcome at the end of the internship led to an offer of employment, providing exciting job opportunities for locally trained graduates.

Our company is a strong supporter of initiatives like McGill’s Doctoral Internship Program, which provide access to highly talented students and contribute to expanding Quebec’s biotech industry.”